West Tower Group LLC Sells 300 Shares of Colgate-Palmolive Company $CL

West Tower Group LLC reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 6.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 4,200 shares of the company’s stock after selling 300 shares during the quarter. West Tower Group LLC’s holdings in Colgate-Palmolive were worth $382,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Grimes & Company Inc. raised its position in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock valued at $1,136,000 after buying an additional 118 shares in the last quarter. RFG Advisory LLC raised its position in Colgate-Palmolive by 1.4% during the second quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock valued at $839,000 after purchasing an additional 123 shares during the period. Redhawk Wealth Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock valued at $497,000 after purchasing an additional 129 shares during the last quarter. MONECO Advisors LLC boosted its holdings in shares of Colgate-Palmolive by 2.2% in the 1st quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock worth $567,000 after purchasing an additional 133 shares during the period. Finally, Ledyard National Bank increased its position in shares of Colgate-Palmolive by 4.5% during the 1st quarter. Ledyard National Bank now owns 3,094 shares of the company’s stock valued at $290,000 after purchasing an additional 134 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $79.14 on Monday. The company’s 50-day simple moving average is $81.96 and its two-hundred day simple moving average is $87.28. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. Colgate-Palmolive Company has a one year low of $76.68 and a one year high of $100.54. The company has a market capitalization of $63.96 billion, a P/E ratio of 22.23, a P/E/G ratio of 4.64 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.Colgate-Palmolive’s quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be issued a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Barclays lowered their price target on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. JPMorgan Chase & Co. lowered their target price on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating for the company in a report on Friday, October 10th. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating on the stock in a report on Thursday, September 25th. Morgan Stanley decreased their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Finally, Deutsche Bank Aktiengesellschaft set a $86.00 target price on Colgate-Palmolive in a research note on Friday, October 10th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.